TALOPH(SH:600222) Zheng Quan Zhi Xing·2025-03-31 11:12Group 1 - The legal opinion letter is regarding the 2025 first extraordinary general meeting of shareholders of Henan Tailong Pharmaceutical Co., Ltd. [1] - The law firm confirms that the documents provided by the company for the meeting are complete, true, and valid [2][3] - The meeting was convened in accordance with relevant laws and regulations, and the procedures followed were deemed legal and effective [5][9] Group 2 - The meeting was called by the company's board of directors, and the qualifications of the attendees were verified [5][6] - A total of 3 shareholders attended the meeting in person, holding 62,133,434 shares, which is 13.2063% of the total voting shares [6] - An additional 330 shareholders participated in the network voting, representing 11,143,262 shares, or 2.3685% of the total voting shares [7] Group 3 - The agenda of the meeting included the proposal regarding the financial support extension from the indirect controlling shareholder [8][9] - The voting results showed that the proposal was approved with 96.9922% of the votes in favor [9][10] - The legal opinion concludes that all aspects of the meeting, including the agenda and voting procedures, complied with the relevant laws and regulations, making the resolutions valid [10][11]